Understanding Health Care Costs in a Wisconsin Acute Leukemia Population

Purpose: We investigated factors driving health care costs of patients with a diagnosis of acute myeloid and acute lymphoblastic leukemia. Methods: Standard costs identified in insurance claims data obtained from the Wisconsin Health Information Organization were used in a sample of 837 acute le...

Full description

Bibliographic Details
Main Authors: Patricia Steinert, Ron A. Cisler
Format: Article
Language:English
Published: Advocate Aurora Health 2016-08-01
Series:Journal of Patient-Centered Research and Reviews
Subjects:
Online Access:http://digitalrepository.aurorahealthcare.org/cgi/viewcontent.cgi?article=1261&context=jpcrr
_version_ 1797934742349283328
author Patricia Steinert
Ron A. Cisler
author_facet Patricia Steinert
Ron A. Cisler
author_sort Patricia Steinert
collection DOAJ
description Purpose: We investigated factors driving health care costs of patients with a diagnosis of acute myeloid and acute lymphoblastic leukemia. Methods: Standard costs identified in insurance claims data obtained from the Wisconsin Health Information Organization were used in a sample of 837 acute leukemia patients from April 2009 to June 2011. The Andersen behavioral model of health care utilization guided selection of patient and community factors expected to influence health care costs. A generalized linear model fitting gamma-distributed data with log-link technique was used to analyze cost. Results: Type of treatment received and disease severity represented significant cost drivers, and patients receiving at least some of their treatment from academic medical centers experienced higher costs. Inpatient care and pharmacy costs of patients who received treatment from providers located in areas of higher poverty experienced lower costs, raising questions of potential treatment and medical practice disparities between provider locations. Directions of study findings were not consistent between different types of services received and underscore the complexity of investigating health care cost. Conclusions: While prevalence of acute leukemia in the United States is low compared to other diseases, its extreme high cost of treatment is not well understood and potentially influences treatment decisions. Acute leukemia health care costs may not follow expected patterns; further exploration of the relationship between cost and the treatment decision, and potential treatment disparities between providers in different socioeconomic locations, is needed.
first_indexed 2024-04-10T18:03:36Z
format Article
id doaj.art-38ee87b6a00c43c4863f6f920ae4ace4
institution Directory Open Access Journal
issn 2330-0698
language English
last_indexed 2024-04-10T18:03:36Z
publishDate 2016-08-01
publisher Advocate Aurora Health
record_format Article
series Journal of Patient-Centered Research and Reviews
spelling doaj.art-38ee87b6a00c43c4863f6f920ae4ace42023-02-02T14:11:03ZengAdvocate Aurora HealthJournal of Patient-Centered Research and Reviews2330-06982016-08-013314214910.17294/2330-0698.1261Understanding Health Care Costs in a Wisconsin Acute Leukemia PopulationPatricia Steinert0Ron A. Cisler1Medical College of Wisconsin, Milwaukee, WIUniversity of Wisconsin-Milwaukee, Milwaukee, WIPurpose: We investigated factors driving health care costs of patients with a diagnosis of acute myeloid and acute lymphoblastic leukemia. Methods: Standard costs identified in insurance claims data obtained from the Wisconsin Health Information Organization were used in a sample of 837 acute leukemia patients from April 2009 to June 2011. The Andersen behavioral model of health care utilization guided selection of patient and community factors expected to influence health care costs. A generalized linear model fitting gamma-distributed data with log-link technique was used to analyze cost. Results: Type of treatment received and disease severity represented significant cost drivers, and patients receiving at least some of their treatment from academic medical centers experienced higher costs. Inpatient care and pharmacy costs of patients who received treatment from providers located in areas of higher poverty experienced lower costs, raising questions of potential treatment and medical practice disparities between provider locations. Directions of study findings were not consistent between different types of services received and underscore the complexity of investigating health care cost. Conclusions: While prevalence of acute leukemia in the United States is low compared to other diseases, its extreme high cost of treatment is not well understood and potentially influences treatment decisions. Acute leukemia health care costs may not follow expected patterns; further exploration of the relationship between cost and the treatment decision, and potential treatment disparities between providers in different socioeconomic locations, is needed.http://digitalrepository.aurorahealthcare.org/cgi/viewcontent.cgi?article=1261&context=jpcrrheatlh care costsacute leukemia costadministrative data use
spellingShingle Patricia Steinert
Ron A. Cisler
Understanding Health Care Costs in a Wisconsin Acute Leukemia Population
Journal of Patient-Centered Research and Reviews
heatlh care costs
acute leukemia cost
administrative data use
title Understanding Health Care Costs in a Wisconsin Acute Leukemia Population
title_full Understanding Health Care Costs in a Wisconsin Acute Leukemia Population
title_fullStr Understanding Health Care Costs in a Wisconsin Acute Leukemia Population
title_full_unstemmed Understanding Health Care Costs in a Wisconsin Acute Leukemia Population
title_short Understanding Health Care Costs in a Wisconsin Acute Leukemia Population
title_sort understanding health care costs in a wisconsin acute leukemia population
topic heatlh care costs
acute leukemia cost
administrative data use
url http://digitalrepository.aurorahealthcare.org/cgi/viewcontent.cgi?article=1261&context=jpcrr
work_keys_str_mv AT patriciasteinert understandinghealthcarecostsinawisconsinacuteleukemiapopulation
AT ronacisler understandinghealthcarecostsinawisconsinacuteleukemiapopulation